Turning Point Therapeutics

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

You can watch TPTX and buy or sell other stocks, options, and ETFs commission-free!

About TPTX

Turning Point Therapeutics is a clinical-stage structure-based drug design company for the discovery and development of precision medicines for cancer and other diseases. They focus on the design of novel chemical identities for established oncogene drivers with secondary resistant mutations, newly identified disease-driven targets, and potential targets regulating the tumor microenvironment and tumor immunity. 

CEO
Athena M. Countouriotis, MD
CEOAthena M. Countouriotis, MD
Employees
250
Employees250
Headquarters
San Diego, California
HeadquartersSan Diego, California
Founded
2013
Founded2013
Employees
250
Employees250

TPTX Key Statistics

Market cap
3.79B
Market cap3.79B
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
1.17M
Average volume1.17M
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$82.20
52 Week high$82.20
52 Week low
$23.77
52 Week low$23.77

TPTX Earnings

-$2.48
-$1.65
-$0.83
$0.00
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Q4 FY22
Estimated
per share
Estimated per share
Actual
Expected Feb 27, After Hours
ActualExpected Feb 27, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.